“From the Bed to the Bench and Back” – A Timeline of Major Breakthroughs by USC Department of Ophthalmology Faculty

1978
Developed a laboratory model of penetrating eye injuries that influences the management of trauma in humans
1979
Developed a laboratory model of choroidal neovascularization now widely used to study pathogenesis and treatment of subretinal neovascularization
1987
Implanted the first artificial cornea in a pediatric patient
Identified the gene that causes retinoblastoma
1992
Addressed vision complications from AIDS by diagnosing and developing treatments for opportunistic eye infections and Kaposi’s sarcoma
1998
Developed the Baerveldt® glaucoma implant for preserving vision in glaucoma patients by reducing eye pressure
1999
Developed a noninvasive glucose-monitoring system using Raman spectrum signals from the aqueous
2000
Began the Los Angeles Latino Eye Study, the world’s largest investigation into eye disease in Latinos
2002
Implanted the first artificial retina in a patient after beginning collaboration with the U.S. Department of Energy Office of Science
2005
Pioneered use of ultra-high speed Fournier domain optical coherence tomography (OCT) to improve glaucoma diagnosis
2009
Identified the unique mechanism of uptake in lacrimal gland for adenovirus 5 that may facilitate drug delivery
2010
Developed a web-accessible visual field test and analysis system for multicenter studies and touchpad device access
2011
Began first clinical trials for an experimental therapeutic agent to treat Leber’s Hereditary Optic Neuropathy, a mitochondrial disease
2013
Received Argus II Retinal Prosthesis System approval by the United States Food and Drug Administration for patients with retinitis pigmentosa
2014
Discovered which retinal cells mutate to become retinoblastoma.
2015
Pioneered use of OCT Angiography for diagnosis and management of retinal vascular diseases

USC Roski Eye Institute patient becomes first to have two artificial retinal prostheses, Argus I and newest generation of Argus II –one in each eye
2016
Researchers discover visual impairment and blindness in the U.S. to double by 2050.

XEN Gel Stent receives FDA approval
2017
Surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors

Developed an on-the-spot, temperature-sensitive reversible superglue to seal eye injuries on the battlefield
2018
First-in-kind stem cell-based retinal implant for dry AMD